Form 4: Bioventus Inc. SVP & CFO Mark Leonard Singleton Reports Stock Transaction
SEC Form 4 Filing
Mark Leonard Singleton, SVP & CFO of Bioventus Inc., reports the vesting of restricted stock units and subsequent acquisition of Class A Common Stock on April 10, 2025.
Summary
- On April 10, 2025, Mark Leonard Singleton, the SVP & CFO of Bioventus Inc., reported a transaction involving restricted stock units (RSUs).
- 13,000 RSUs vested, each representing a contingent right to receive one share of Class A common stock.
- Upon vesting, Singleton acquired 13,000 shares of Class A Common Stock.
- The transaction was executed pursuant to the terms of the RSU agreement.
- Following the reported transaction, Singleton directly owns 144,963 shares of Class A Common Stock and 26,000 Restricted Stock Units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to executive compensation. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.
Stakeholder Impact
- The transaction may have a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| 04/10/2023 | Initial grant date of the Restricted Stock Units, vesting in four equal installments on each of the first four anniversaries. |
| 04/10/2025 | Date of transaction: Vesting of 13,000 Restricted Stock Units and acquisition of 13,000 shares of Class A Common Stock. |
| 04/11/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Bioventus Inc., BVS, Mark Leonard Singleton, SVP & CFO, Restricted Stock Units, Class A Common Stock, Beneficial Ownership, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.